Topics

Iomab-B Leads to High Bone Marrow Transplant Rate in Relapsed/Refractory AML

17:54 EDT 28 Oct 2019 | OncLive

Treatment with iodine-131 apamistamab led to a high bone marrow transplant rate compared with salvage chemotherapy in elderly patients with relapsed/refractory acute myeloid leukemia.

Original Article: Iomab-B Leads to High Bone Marrow Transplant Rate in Relapsed/Refractory AML

NEXT ARTICLE

More From BioPortfolio on "Iomab-B Leads to High Bone Marrow Transplant Rate in Relapsed/Refractory AML"

Quick Search

Relevant Topics

Osteoporosis
Osteoporosis is a disease in which the bones become extremely porous, are subject to fracture, and heal slowly, occurring especially in women following menopause and often leading to curvature of the spine from vertebral collapse. Follow and track&n...

Transplantation
Organ transplantation is the moving of an organ from one body to another or from a donor site to another location on the patient's own body, for the purpose of replacing the recipient's damaged or absent organ. The emerging field of regenerative ...